Diabetes Autoimmune Reactivity Screen™

Array 6 - Diabetes Autoimmune Reactivity Screen™

Assesses markers of the autoimmune components of diabetes. Can be used as a tool to identify reactivity prior to the onset of diabetes, and to monitor a patient who is already diagnosed with diabetes to see how well treatment protocols are working.

Clinical Use

Recommended for Patients Who

Antigens Tested (IgG + IgA Combined)

  • Glutamic Acid Decarboxylase 65 (GAD65)
  • Insulin + Islet Cell Antigen

    CPT® CODE : 83516 (x2)

    Potential Molecular Mechanisms Where Loss of Tolerance Exists

    Illustration dramatized for visual purposes. © Cyrex Laboratories, LLC. All rights reserved.